1,258 reports of this reaction
6.7% of all MISOPROSTOL reports
#1 most reported adverse reaction
HAEMORRHAGE is the #1 most commonly reported adverse reaction for MISOPROSTOL, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 1,258 FDA adverse event reports linking MISOPROSTOL to HAEMORRHAGE. This represents approximately 6.7% of all 18,857 adverse event reports for this drug.
Patients taking MISOPROSTOL who experience haemorrhage should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HAEMORRHAGE is moderately reported among MISOPROSTOL users, representing a notable but not dominant share of adverse events.
In addition to haemorrhage, the following adverse reactions have been reported for MISOPROSTOL:
The following drugs have also been linked to haemorrhage in FDA adverse event reports:
HAEMORRHAGE has been reported as an adverse event in 1,258 FDA reports for MISOPROSTOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
HAEMORRHAGE accounts for approximately 6.7% of all adverse event reports for MISOPROSTOL, making it one of the most commonly reported side effect.
If you experience haemorrhage while taking MISOPROSTOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.